- Home
- UDMY vs AQST Comparison
UDMY vs AQST Comparison
Compare UDMY & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UDMY
- AQST
- Stock Information
- Founded
- UDMY 2009
- AQST 2004
- Country
- UDMY United States
- AQST United States
- Employees
- UDMY N/A
- AQST N/A
- Industry
- UDMY Other Consumer Services
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- UDMY Real Estate
- AQST Health Care
- Exchange
- UDMY Nasdaq
- AQST Nasdaq
- Market Cap
- UDMY 1.0B
- AQST 809.3M
- IPO Year
- UDMY 2021
- AQST 2018
- Fundamental
- Price
- UDMY $5.12
- AQST $5.72
- Analyst Decision
- UDMY Buy
- AQST Strong Buy
- Analyst Count
- UDMY 10
- AQST 7
- Target Price
- UDMY $9.67
- AQST $10.00
- AVG Volume (30 Days)
- UDMY 2.2M
- AQST 2.8M
- Earning Date
- UDMY 10-29-2025
- AQST 11-05-2025
- Dividend Yield
- UDMY N/A
- AQST N/A
- EPS Growth
- UDMY N/A
- AQST N/A
- EPS
- UDMY N/A
- AQST N/A
- Revenue
- UDMY $795,801,000.00
- AQST $43,397,000.00
- Revenue This Year
- UDMY $2.52
- AQST N/A
- Revenue Next Year
- UDMY $2.48
- AQST $51.39
- P/E Ratio
- UDMY N/A
- AQST N/A
- Revenue Growth
- UDMY 2.53
- AQST N/A
- 52 Week Low
- UDMY $4.86
- AQST $2.12
- 52 Week High
- UDMY $10.61
- AQST $7.55
- Technical
- Relative Strength Index (RSI)
- UDMY 33.66
- AQST 44.65
- Support Level
- UDMY $4.86
- AQST $5.21
- Resistance Level
- UDMY $5.39
- AQST $6.17
- Average True Range (ATR)
- UDMY 0.18
- AQST 0.44
- MACD
- UDMY 0.00
- AQST -0.05
- Stochastic Oscillator
- UDMY 35.07
- AQST 30.49
About UDMY Udemy Inc.
Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.